Search

everythinglearnresearchcommunity

for

Search:↓

PRP and HF-MSCs treatment improves hair growth, thickness, and density in androgenetic alopecia.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Researchers found 63 genes linked to male-pattern baldness, which could help in understanding its biology and developing new treatments.

Using CRISPR for gene editing in the body is promising but needs better delivery methods to be more efficient and specific.

Fadrozole and finasteride change gene expression related to sex hormones and thyroid hormones in frog larvae development.

Lower levels of certain brain chemicals are linked to worse PTSD symptoms in men.

Post-finasteride patients show changed neuroactive steroid levels, possibly causing erectile dysfunction and depression.

Researchers found 71 genetic regions linked to male pattern baldness, which account for 38% of its genetic risk.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Certain drugs that block specific enzymes can help treat prostate diseases.

Genes and hormones cause hair loss, with four genes contributing equally.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Hair diversity is influenced by complex genetics and environmental factors, requiring more research for practical solutions.

Finasteride helps treat hair loss and prostate enlargement by blocking a specific enzyme.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Current treatments for male pattern baldness include minoxidil and finasteride, with new options being developed.

5-alpha reductase deficiency leads to male sexual development issues and treatments like finasteride help with prostate enlargement and hair loss.

Dihydrotestosterone can be made from dehydroepiandrosterone in skin cells without needing testosterone.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Stress and alcohol affect brain chemicals differently in rats, mice, and humans, influenced by genetic differences.

Finasteride treatment changes brain steroid levels and receptors, affecting brain function even after stopping treatment.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Herbal compounds like ricinoleic acid, quercetin-3-O-rutinoside, and hinokiflavone may be safe and effective for treating hair loss.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.